foxo4-dri senolytic human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Anti-senescence therapies: a new concept
Description
Such effects are particularly likely when the task itself involves external rewards (Eikemo et al., 2017) or when performance on tasks is perceived to reflect intelligence or capability
331UchidaTRossignolFMatthayMAMounierRCouetteSClottesEClericiC
AIDS Research and Therapy
If you have kidney failure and you don't want dialysis or a kidney transplant, you'll likely live only a few months
